Doctors believe new test could lead to earlier diagnoses and more effective treatment for thousands of patients ...
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback